Moleculin Biotech Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Good afternoon as we continue with day two of the 33rd Annual Oppenheimer Healthcare Conference. I'm delighted to welcome Moleculin CFO, Jon Foster, to the call. Jon, I will hand it off to you to introduce an update on the Moleculin story.
Thanks, Jeff, and hello, everyone. I'm Jon Foster, Executive Vice President and CFO of Moleculin Biotech.
It's a great pleasure for me to present the Moleculin story, and I'd like to thank Oppenheimer for this opportunity. Our Co-Founder and CEO, Wally Klemp normally does these presentations, but currently, he's over in Europe visiting some of our clinical sites with our Senior Chief Medical Officer to discuss some of our ongoing trials face to face with the local site clinical investigators, so you got me for today.
You'll see the importance of this as I get into our pipeline, the importance of Wally being over in Europe, talking to our clinical investigators with regard to our pipeline and our clinical
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
